HIV-1 Vpu's lipid raft association is dispensable for counteraction of the particle release restriction imposed by CD317/Tetherin (Q39417033)

11 September 2017

title

HIV-1 Vpu's lipid raft association is dispensable for counteraction of the particle release restriction imposed by CD317/Tetherin (English)

1 reference

11 September 2017

1 reference

Oliver T Fackler

4

0 references

Joëlle V. Fritz

series ordinal

1

object named as

Joëlle V Fritz

1 reference

11 September 2017

Nadine Tibroni

2

1 reference

11 September 2017

Oliver T Keppler

series ordinal

3

1 reference

11 September 2017

language of work or name

English

0 references

publication date

4 January 2012

1 reference

11 September 2017

1 reference

11 September 2017

volume

424

1 reference

11 September 2017

issue

1

1 reference

11 September 2017

page(s)

33-44

1 reference

Differential effects of human immunodeficiency virus type 1 Vpu on the stability of BST-2/tetherin

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

A flow cytometry-based FRET assay to identify and analyse protein-protein interactions in living cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Erlin-1 and erlin-2 are novel members of the prohibitin family of proteins that define lipid-raft-like domains of the ER

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Suppression of Tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi network

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

In vivo expression profile of the antiviral restriction factor and tumor-targeting antigen CD317/BST-2/HM1.24/tetherin in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Specific and distinct determinants mediate membrane binding and lipid raft incorporation of HIV-1(SF2) Nef.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Antagonism of CD317 restriction of human immunodeficiency virus type 1 (HIV-1) particle release and depletion of CD317 are separable activities of HIV-1 Vpu.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Structural basis of HIV-1 tethering to membranes by the BST-2/tetherin ectodomain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Human immunodeficiency virus type 1 assembly and lipid rafts: Pr55(gag) associates with membrane domains that are largely resistant to Brij98 but sensitive to Triton X-100

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that may be involved in pre-B-cell growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Broad-spectrum inhibition of retroviral and filoviral particle release by tetherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor Nef

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Identification of amino acids in the human tetherin transmembrane domain responsible for HIV-1 Vpu interaction and susceptibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Human immunodeficiency virus type 1 Nef activates p21-activated kinase via recruitment into lipid rafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Vpu-mediated tetherin antagonism of ongoing HIV-1 infection in CD4(+) T-cells is not directly related to the extent of tetherin cell surface downmodulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Role of the endocytic pathway in the counteraction of BST-2 by human lentiviral pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Monocyte lipid rafts contain proteins implicated in vesicular trafficking and phagosome formation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Myristoylation as a target for inhibiting HIV assembly: unsaturated fatty acids block viral budding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Lipid rafts as a membrane-organizing principle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

HM1.24 is internalized from lipid rafts by clathrin-mediated endocytosis through interaction with alpha-adaptin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Flotillins and the PHB domain protein family: rafts, worms and anaesthetics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Evidence for budding of human immunodeficiency virus type 1 selectively from glycolipid-enriched membrane lipid rafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Plasma membrane rafts play a critical role in HIV-1 assembly and release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Tetherin inhibits HIV-1 release by directly tethering virions to cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Effects of signal peptide exchange on HIV-1 glycoprotein expression and viral infectivity in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Human immunodeficiency virus type 1 Nef recruits the guanine exchange factor Vav1 via an unexpected interface into plasma membrane microdomains for association with p21-activated kinase 2 activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Clathrin-mediated endocytosis of a lipid-raft-associated protein is mediated through a dual tyrosine motif.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Membrane raft association of the Vpu protein of human immunodeficiency virus type 1 correlates with enhanced virus release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Inhibition of Lassa and Marburg virus production by tetherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

HIV-1 Vpu blocks recycling and biosynthetic transport of the intrinsic immunity factor CD317/tetherin to overcome the virion release restriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Compensatory changes in the cytoplasmic tail of gp41 confer resistance to tetherin/BST-2 in a pathogenic nef-deleted SIV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Functional rafts in cell membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Hydrophobic substitutions in the first residue of the CRAC segment of the gp41 protein of HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Structural insight into the mechanisms of enveloped virus tethering by tetherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Budding capability of the influenza virus neuraminidase can be modulated by tetherin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

Biochemical and proteomic approaches for the study of membrane microdomains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2011.12.008

10.1016/J.VIROL.2011.12.008

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference